Eliquis 5mg Recall: Label Mix-Up with 2.5mg Tablets
Bristol-Myers Squibb recalls Eliquis 5mg bottles due to a labeling error where lower-strength 2.5mg tablets were found inside.
Stop using this now
Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.
Contact the company
What happened, in plain English
Bristol-Myers Squibb is recalling one bottle of Eliquis 5mg tablets because the label was incorrect. The bottle contained only lower-strength 2.5mg tablets instead of the labeled 5mg dose. This error affects a specific lot distributed nationwide in the US. Read more at govinfonow.com/recall/41585-eliquis-5mg-recall-label-mix-up-with-2-5mg-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/41585-eliquis-5mg-recall-label-mix-up-with-2-5mg-tablets · Updated October 11, 2026 · FDA enforcement record: FDA #D-0959-2017
Cite this page
“Eliquis 5mg Recall: Label Mix-Up with 2.5mg Tablets.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41585-eliquis-5mg-recall-label-mix-up-with-2-5mg-tablets. Based on FDA recall #D-0959-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0959-2017%22&limit=1).
Why it’s dangerous
Taking a lower dose of blood thinner than prescribed can reduce the medication's effectiveness in preventing strokes or blood clots. This increases the risk of serious health complications for patients relying on the correct dosage.
Who’s affected
Patients prescribed Eliquis 5mg tablets who purchased the affected bottle from pharmacies or retailers nationwide between the manufacturing date and the recall announcement.
How to tell if you have this one
Check your Eliquis bottle for NDC 0003-0894-21 and Lot number HN0063 with an expiration date of 09/2019. The label should indicate 'Eliquis Tablets 5mg, 60 count bottle'.
- Brand
Eliquis- Category
Drug
What to do — step by step
Stop taking the medication
Do not consume any tablets from the recalled bottle until you have consulted your healthcare provider.
Contact your doctor
Speak with your healthcare provider immediately to discuss alternative treatment options and ensure your therapy is not interrupted.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 4.8 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0959-2017 (June 5, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0959-2017 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.